Genotype-Guided Dosing of Coumarin Anticoagulants

Genetics of warfarin dosing—one polymorphism at a time

(2013) Mark J Alberts   LANCET

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study

(2013) Minoli A Perera et al.   LANCET

A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon

(2013) Talitha I. Verhoef et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing

(2013) Stephen E. Kimmel et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Trial of Genotype-Guided Dosing of Warfarin

(2013) Munir Pirmohamed et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of genotype-guided dosing on anticoagulation visits for adults starting warfarin: a randomized controlled trial

(2013) Daniel E Jonas et al.   PHARMACOGENOMICS

Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials

(2013) Subodh Verma et al.   Lancet Diabetes & Endocrinology

Executive Summary

(2012) Gordon H. Guyatt et al.   CHEST

A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)

(2012) Jeffrey L. Anderson et al.   CIRCULATION

Genotype-Based Dosing Algorithms for Warfarin Therapy

(2012) Eric G. Johnson et al.   Molecular Diagnosis & Therapy

Research and Statistics: Quantifying Associations: Understanding Relative Risks and Odds Ratios

(2012) K. A. Connor   PEDIATRICS IN REVIEW

Prospective pilot trial of PerMIT versus standard anticoagulation service management of patients initiating oral anticoagulation

(2012) Mark P. Borgman et al.   THROMBOSIS AND HAEMOSTASIS

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation

(2012) Nita A. Limdi   Frontiers in Pharmacology

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing

(2011) J A Johnson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Missing Association: Sequencing-Based Discovery of Novel SNPs in VKORC1 and CYP2C9 That Affect Warfarin Dose in African Americans

(2011) M A Perera et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A randomized controlled trial of genotype-based Coumadin initiation

(2011) James K Burmester et al.   GENETICS IN MEDICINE

Pharmacogenetics of Oral Anticoagulant Therapy

(2009) T. Schalekamp et al.   CURRENT PHARMACEUTICAL DESIGN

Understanding heterogeneity in meta-analysis: the role of meta-regression

(2009) W. L. Baker et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of Warfarin

(2009) Kirsten Neudoerffer Kangelaris et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients

(2009) Sheng-Wen Huang et al.   Pharmacogenetics and Genomics

CYP4F2 genetic variant alters required warfarin dose

(2008) M. D. Caldwell et al.   BLOOD

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

(2008) BF Gage et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Understanding the pharmacogenetic approach to warfarin dosing

(2008) Ingrid Glurich et al.   HEART FAILURE REVIEWS